Trump’s FDA Cuts Are Putting Drug Development at Risk

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals…

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals…
Read More

About Author

Caroline Haskins

See author's posts

Trump’s FDA Cuts Are Putting Drug Development at Risk

About Author

Caroline Haskins

How cancer hijacks the immune system by draining T cells’ energy

Nearly 1 in 5 US college athletes reports abusive supervision by their coaches

More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050

How cancer hijacks the immune system by draining T cells’ energy

Contraction inhibitors after 30 weeks have no effect on baby’s health, study shows

More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050

Nearly 1 in 5 US college athletes reports abusive supervision by their coaches

Trump’s FDA Cuts Are Putting Drug Development at Risk

What Happened to Patient Portal Messages After a Health System Billed for Them?

Take these steps to protect yourself from winter weather dangers

Mediterranean diet linked to improved memory via gut bacteria changes

7 surprising ways to make 2025 healthy

Why some people’s hair and nails grow quicker than others

How cancer hijacks the immune system by draining T cells’ energy

Contraction inhibitors after 30 weeks have no effect on baby’s health, study shows

More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050

Nearly 1 in 5 US college athletes reports abusive supervision by their coaches

Trump’s FDA Cuts Are Putting Drug Development at Risk

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories